Axsome Therapeutics
AXSM
AXSM
395 hedge funds and large institutions have $6.86B invested in Axsome Therapeutics in 2025 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 139 increasing their positions, 122 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 122
12% more funds holding
Funds holding: 353 → 395 (+42)
0.14% more ownership
Funds ownership: 74.52% → 74.66% (+0.14%)
Holders
395
Holding in Top 10
13
Calls
$167M
Puts
$117M
Top Buyers
| 1 | +$66M | |
| 2 | +$39.5M | |
| 3 | +$35.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$35.4M |
| 5 |
D.E. Shaw & Co
New York
|
+$35.3M |
Top Sellers
| 1 | -$132M | |
| 2 | -$99M | |
| 3 | -$61.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$53.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$38.9M |
